Extension of our findings to a larger dataset (TCGA) emphasizes the potential significance of integrin signaling, ubiquitin-mediated proteolysis, and TGF-beta receptor signaling in HER2-positive breast cancer, and suggests that processes linked to M-phase may also be of particular importance in this breast cancer subtype. This evidence concerns the gene ERBB2 and breast carcinoma.